Company intelligence / Profile preview

Tetra Natural Health

Ottawa, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Developed OTC topical and other products based on beta-caryophyllene for pain and skin conditions; advanced to DIN submissions in Canada and NDC prep in USA, targeting commercialization

Therapeutic areas: Infectious DiseasesRheumatologyDermatologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Azevedos (distribution in Portugal/Mozambique/Tunisia, export to 60+ countries)Crescita Therapeutics (transdermal delivery enhancement)Cellvera Global Holdings (co-development via parent)

Beyond the preview

Go deeper on Tetra Natural Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetra Natural Health.

Explore the full profile